{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:32:17Z","timestamp":1795026737130,"version":"4.10.2"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-04163-7","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T12:06:16Z","timestamp":1764158776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and predictors of cervical lesions among women on ART in the Awi Zone, Northwest Ethiopia: facility-based cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Kelemework Gashinet","family":"Ferede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berihun","family":"Bantie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asiya Mohammed","family":"Abdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addisu Gasheneit","family":"Ferede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Shitu","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebiaw Wudie","family":"Thegaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"4163_CR1","doi-asserted-by":"crossref","unstructured":"Wright TC, Ronnett BM, Kurman RJ. Precancerous lesions of the cervix. Blaustein\u2019s pathology of the female genital tract. edn.: Springer; 2018. pp. 1\u201375.","DOI":"10.1007\/978-1-4614-3165-7_5-2"},{"issue":"10","key":"4163_CR2","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1158\/1055-9965.EPI-12-0535","volume":"21","author":"TW Markossian","year":"2012","unstructured":"Markossian TW, Darnell JS, Calhoun EA. Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program. Cancer Epidemiol Biomarkers Prev. 2012;21(10):1691\u2013700.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4163_CR3","unstructured":"Organization WH. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. World Health Organization; 2021."},{"issue":"4","key":"4163_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Mu\u00f1oz N, Meijer C, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244\u201365.","journal-title":"J Clin Pathol"},{"issue":"1","key":"4163_CR5","doi-asserted-by":"publisher","first-page":"107327481984587","DOI":"10.1177\/1073274819845872","volume":"26","author":"F Weldegebreal","year":"2019","unstructured":"Weldegebreal F, Worku T. Precancerous cervical lesion among HIV-positive women in sub-Saharan Africa: a systematic review and meta-analysis. Cancer Control. 2019;26(1):1073274819845872.","journal-title":"Cancer Control"},{"key":"4163_CR6","unstructured":"ESMO: FIRST GLOBAL ESTIMATES OF CERVICAL CANCER ATTRIBUTABLE to HIV,Epidemiology\/Etiology\/Cancer Prevention. Gynaecologic malignancies,the Lancet Globl Health (2022),Available from https:\/\/www.esmo.org\/oncology-news\/first-global-estimates-of-cervical-cancer-attributable-to-hiv citedon(8\/21\/2022). 2022."},{"key":"4163_CR7","unstructured":"UNAIDS. The little-known links between cervical cancer and HIAvailable:https:\/\/www.unaids.org\/en\/resources\/presscentre\/featurestories\/2019\/may\/20190531_cervical-cancer-hiv cited on(9\/19\/2022). 2019."},{"issue":"1","key":"4163_CR8","doi-asserted-by":"publisher","first-page":"107327481879795","DOI":"10.1177\/1073274818797955","volume":"25","author":"N Rihana","year":"2018","unstructured":"Rihana N, Nanjappa S, Sullivan C, Velez AP, Tienchai N, Greene JN. Malignancy trends in HIV-infected patients over the past 10 years in a single-center retrospective observational study in the United States. Cancer Control. 2018;25(1):1073274818797955.","journal-title":"Cancer Control"},{"key":"4163_CR9","unstructured":"WHO. WHO releases new estimates of the global burden of cervical cancer associated with HIV, Available from https:\/\/www.who.int\/news\/item\/16-11-2020-who-releases-new-estimates-of-the-global-burden-of-cervical-cancer-associated-with-hiv cited on (8\/21\/2022). 2021."},{"key":"4163_CR10","unstructured":"WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem,Available from: file:\/\/\/C:\/Users\/h\/AppData\/Local\/Temp\/9789240014107-eng.pdf. 2020."},{"issue":"3","key":"4163_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/ijc.32260","volume":"146","author":"E Rohner","year":"2020","unstructured":"Rohner E, B\u00fctikofer L, Schmidlin K, Sengayi M, Maskew M, Giddy J, Taghavi K, Moore RD, Goedert JJ, Gill MJ. Cervical cancer risk in women living with HIV across four continents: a multicohort study. Int J Cancer. 2020;146(3):601\u20139.","journal-title":"Int J Cancer"},{"issue":"12","key":"4163_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.14423\/SMJ.0000000000001184","volume":"113","author":"E Oduguwa","year":"2020","unstructured":"Oduguwa E, Dongarwar D, Salihu HM. Trends in premature deaths among women living with HIV\/AIDS and cervical cancer. South Med J. 2020;113(12):651\u20138.","journal-title":"South Med J"},{"issue":"6","key":"4163_CR13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1089\/jwh.2019.7858","volume":"29","author":"R Shah","year":"2020","unstructured":"Shah R, et al. Economic and humanistic burden of cervical cancer in the United States: results from a nationally representative survey. J Womens Health. 2020;29(6):799\u2013805.","journal-title":"J Womens Health"},{"key":"4163_CR14","doi-asserted-by":"publisher","unstructured":"Fauk NK,\u00a0Mwanri L, Hawke K, Mohammadi L, Ward PR. Psychological and social impact of HIV on women living with HIV\u00a0and their families in low- and middle-income Asian Countries: a systematic search and critical review.\u00a0Int J Environ Res Public Health. 2022;19(11):6668. https:\/\/doi.org\/10.3390\/ijerph19116668.","DOI":"10.3390\/ijerph19116668"},{"key":"4163_CR15","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2147\/CMAR.S352389","volume":"14","author":"H Endale","year":"2022","unstructured":"Endale H, Mulugeta T, Habte T. The socioeconomic impact of cervical cancer on patients in Ethiopia: evidence from Tikur Anbessa specialized hospital. Cancer Manag Res. 2022;14:1615.","journal-title":"Cancer Manag Res"},{"issue":"31","key":"4163_CR16","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1200\/JCO.2016.67.9613","volume":"34","author":"S Dryden-Peterson","year":"2016","unstructured":"Dryden-Peterson S, et al. HIV infection and survival among women with cervical cancer. J Clin Oncol. 2016;34(31):3749.","journal-title":"J Clin Oncol"},{"key":"4163_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s40615-020-00751-5","volume":"8","author":"H Salihu","year":"2021","unstructured":"Salihu H, et al. Racial\/ethnic disparities in the burden of HIV\/cervical cancer comorbidity and related in-hospital mortality in the USA. J Racial Ethn Health Disparities. 2021;8:24\u201332.","journal-title":"J Racial Ethn Health Disparities"},{"key":"4163_CR18","unstructured":"Liron Pantanowitz MFD. MD: HIV infection and malignancy: Management considerations,Available from: https:\/\/www.uptodate.com\/contents\/hiv-infection-and-malignancy-management-considerations\/print cited on(9\/19\/2022). 2022."},{"issue":"3","key":"4163_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/0956462413491735","volume":"25","author":"SA Denslow","year":"2014","unstructured":"Denslow SA, Rositch AF, Firnhaber C, Ting J, Smith JS. Incidence and progression of cervical lesions in women with HIV: a systematic global review. Int J STD AIDS. 2014;25(3):163\u201377.","journal-title":"Int J STD AIDS"},{"key":"4163_CR20","volume":"6","author":"F D\u2019Andrea","year":"2019","unstructured":"D\u2019Andrea F, Pellican\u00f2 G, Venanzi Rullo E, d\u2019Aleo F, Facciol\u00e0 A, Micali C, et al. Cervical cancer in women living with HIV: a review of the literature. World Cancer Res J. 2019;6:e1224.","journal-title":"World Cancer Res J"},{"key":"4163_CR21","unstructured":"Mbu R. Co-morbidity of HIV and Cervical Cancer: A One Year Multicentric Pilot Study in Cameroon. Journal of HIV. 2019;5(1):2Mbu R. Co-morbidity of HIV and Cervical Cancer: A One Year Multicentric Pilot Study in Cameroon. Journal of HIV. 2019;5(1):2."},{"issue":"10","key":"4163_CR22","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.31557\/APJCP.2019.20.10.2987","volume":"20","author":"CO Ogu","year":"2019","unstructured":"Ogu CO, Achukwu PU, Nkwo PO. Prevalence and risk factors of cervical dysplasia among human immunodeficiency virus sero-positive females on highly active antiretroviral therapy in Enugu, Southeastern, Nigeria. Asian Pac J Cancer Prevention: APJCP. 2019;20(10):2987.","journal-title":"Asian Pac J Cancer Prevention: APJCP"},{"issue":"2","key":"4163_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ijgo.13312","volume":"151","author":"GO Daniel","year":"2020","unstructured":"Daniel GO, Musa J, Akindigh TM, Shinku F, Shuaibu SI, Kwaghe B, et al. Prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, north-central Nigeria. Int J Gynaecol Obstet. 2020;151(2):253\u20139.","journal-title":"Int J Gynaecol Obstet"},{"key":"4163_CR24","doi-asserted-by":"crossref","unstructured":"Zelalem W, Weldegebreal F, Ayele BH, Deressa A, Debella A, Eyeberu A, et al. Precancerous cervical lesion among adult women with human immune deficiency virus on anti retroviral therapy at saint Peter specialized Hospital, Ethiopia: a Hospital-Based Cross-Sectional study frontiers in oncology. Front Oncol. 2022;12.","DOI":"10.3389\/fonc.2022.910915"},{"issue":"1","key":"4163_CR25","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.4314\/ahs.v19i1.46","volume":"19","author":"LS Kassa","year":"2019","unstructured":"Kassa LS, Dile WM, Zenebe GK, Berta AM. Precancerous lesions of cervix among women infected with HIV in referral hospitals of Amhara Region, Northwest ethiopia: a cross sectional study. Afr Health Sci. 2019;19(1):1695\u2013704.","journal-title":"Afr Health Sci"},{"key":"4163_CR26","unstructured":"Belayneh T, Mitiku H, Weldegebreal F. Precancerous cervical lesion and its associated factors among HIV-infected women on ART in Amhara regional State, ethiopia: a hospital-based cross-sectional study. Int J Health Sci. 2019;13(3):4\u20139.\u00a0PMID:31123433; PMCID: PMC6512148."},{"issue":"1","key":"4163_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-9378-8-45","volume":"8","author":"L Kafuruki","year":"2013","unstructured":"Kafuruki L, Rambau PF, Massinde A, Masalu N. Prevalence and predictors of cervical intraepithelial neoplasia among HIV infected women at Bugando medical Centre, Mwanza-Tanzania. Infect Agents Cancer. 2013;8(1):1\u20138.","journal-title":"Infect Agents Cancer"},{"key":"4163_CR28","doi-asserted-by":"publisher","first-page":"117693512110684","DOI":"10.1177\/11769351211068431","volume":"20","author":"M Mekuria","year":"2021","unstructured":"Mekuria M, Edosa K, Endashaw M, Bala ET, Chaka EE, Deriba BS, et al. Prevalence of cervical cancer and associated factors among women attended cervical cancer screening center at Gahandi memorial Hospital, Ethiopia. Cancer Inform. 2021;20:11769351211068431.","journal-title":"Cancer Inform"},{"key":"4163_CR29","unstructured":"Federal Ministry Of Health (FMOH). National_Comprehensive_HIV Care guideline in Ethiopia. Addis Ababa: Federal Ministry of Health. (2021). Available online at: https:\/\/www.afro.who.int\/sites\/default\/files\/2019-04\/National20Comprehensive%20HIV%20Care%20%20Guideline%202018.pdf"},{"issue":"7","key":"4163_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181156","volume":"12","author":"L Sigfrid","year":"2017","unstructured":"Sigfrid L, Murphy G, Haldane V, Chuah FLH, Ong SE, Cervero-Liceras F, et al. Integrating cervical cancer with HIV healthcare services: a systematic review. PLoS One. 2017;12(7):e0181156.","journal-title":"PLoS One"},{"key":"4163_CR31","doi-asserted-by":"publisher","unstructured":"Stelzle D, Tanaka LF, Lee KK, IbrahimKhalil A, Baussano I, Shah ASV, McAllister DA, Gottlieb SL, Klug SJ, Winkler AS, Bray F, Baggaley R, Clifford GM,Broutet N, Dalal S.\u00a0Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021;9(2):e161\u20139. https:\/\/doi.org\/10.1016\/S2214-109X(20)30459-9.","DOI":"10.1016\/S2214-109X(20)30459-9"},{"key":"4163_CR32","unstructured":", World Health Organizations (WHO), Initiatives CCE. Availabl from https:\/\/www.who.int\/health-topics\/cervical-cancer#tab=tab_1cited(8\/18\/2022). 2021."},{"key":"4163_CR33","unstructured":"Ceneter of Diseases Control (CDC). Cervical Cancer Factsheet,(Incide About Gynecologic Cancer2018),available from: https:\/\/www.cdc.gov\/cancer\/cervical\/pdf\/cervical_facts.pdf,citedon(9\/14\/2022. 2018."},{"key":"4163_CR34","unstructured":"WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem, Accessed from https:\/\/iris.who.int\/bitstream\/handle\/10665\/336583\/9789240014107-eng.pdf?sequence=1. 2020."},{"key":"4163_CR35","unstructured":"WHO: New WHO recommendations on screening and treatment to prevent cervical cancer among women living with HIV. (2021),Available from https:\/\/www.who.int\/publications\/i\/item\/9789240030961. 2021."},{"key":"4163_CR36","unstructured":"Federal Ministory of Health of Ethiopia (FMOH). National guidelines for comprehensive HIV Prevention, care and treatment. PDF; 2022."},{"key":"4163_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7071925","author":"B Dessalegn Mekonnen","year":"2020","unstructured":"Dessalegn Mekonnen B. Cervical cancer screening uptake and associated factors among HIV- positive women in Ethiopia: a systematic review and meta-analysis. Adv Prev Med. 2020. https:\/\/doi.org\/10.1155\/2020\/7071925.","journal-title":"Adv Prev Med"},{"key":"4163_CR38","doi-asserted-by":"crossref","unstructured":"Mungo C, Barker E, Randa M, Ambaka J, Osongo CO. Integration of cervical cancer screening into HIV\/AIDS care in low-income countries: a moral imperative. ecancermedicalscience 2021, 15.","DOI":"10.3332\/ecancer.2021.1237"},{"key":"4163_CR39","unstructured":"Towns. and villages in Agew Awi zone, Avaliable on: https:\/\/townsvillages.com\/ethiopia\/amhara\/agew-awi-zone\/ cited on 21\/06\/2025."},{"key":"4163_CR40","unstructured":"Ethiopian Statistical Service. Population-of-Zones-and-Weredas-Projected-as-of-July-2023, avaliable on: https:\/\/ess.gov.et\/download\/population-of-zones-and-weredas-projected-as-of-july-2023\/"},{"key":"4163_CR41","unstructured":"Awi zone Health Department. Zonal Health department annual report., Northwest Ethiopia 2022 G.C."},{"issue":"1","key":"4163_CR42","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1186\/s12879-024-10098-5","volume":"24","author":"T Menberu","year":"2024","unstructured":"Menberu T, Amera TG, Addisu A, Getie M. Magnitude of anemia and associated factors among HIV infected children on antiretroviral therapy in Awi zone health facilities, Northwest Ethiopia, 2023. BMC Infect Dis. 2024;24(1):1207.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"4163_CR43","doi-asserted-by":"publisher","first-page":"e84519","DOI":"10.1371\/journal.pone.0084519","volume":"8","author":"A Gedefaw","year":"2013","unstructured":"Gedefaw A, Astatkie A, Tessema GA. The prevalence of precancerous cervical cancer lesion among HIV-infected women in Southern ethiopia: a cross-sectional study. PLoS One. 2013;8(12):e84519.","journal-title":"PLoS One"},{"key":"4163_CR44","unstructured":"Sax P. Techniques and interpretation of measurement of the CD4 cell count in people with HIV. In.: UpToDate, Wolters Kluwer, Netherlands; 2021."},{"key":"4163_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2471\/BLT.13.122051","volume":"92","author":"MJ Huchko","year":"2014","unstructured":"Huchko MJ, Sneden J, Leslie HH, Abdulrahim N, Maloba M, Bukusi E, Cohen CR. A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya. Bull World Health Organ. 2014;92:195\u2013203.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"4163_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-017-4120-3","volume":"17","author":"PE Jolly","year":"2017","unstructured":"Jolly PE, Mthethwa-Hleta S, Padilla LA, Pettis J, Winston S, Akinyemiju TF, Turner HJ, Ejiawoko A, Brooks R, Preko L. Screening, prevalence, and risk factors for cervical lesions among HIV positive and HIV negative women in Swaziland. BMC Public Health. 2017;17(1):1\u20138.","journal-title":"BMC Public Health"},{"issue":"1","key":"4163_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4103\/0971-5916.178614","volume":"143","author":"J Chakravarty","year":"2016","unstructured":"Chakravarty J, Chourasia A, Thakur M, Singh AK, Sundar S, Agrawal NR. Prevalence of human papillomavirus infection & cervical abnormalities in HIV-positive women in Eastern India. Indian J Med Res. 2016;143(1):79.","journal-title":"Indian J Med Res"},{"key":"4163_CR48","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S295137","author":"LG Lemu","year":"2021","unstructured":"Lemu LG, Woldu BF, Teke NE, Bogale ND, Wondimenew EA. Precancerous cervical lesions among HIV-infected women attending HIV care and treatment clinics in Southwest ethiopia: a cross- sectional study. Int J Womens Health. 2021. https:\/\/doi.org\/10.2147\/IJWH.S295137.","journal-title":"Int J Womens Health"},{"issue":"1","key":"4163_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12907-015-0016-2","volume":"15","author":"M Getinet","year":"2015","unstructured":"Getinet M, Gelaw B, Sisay A, Mahmoud EA, Assefa A. Prevalence and predictors of pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia. BMC Clin Pathol. 2015;15(1):1\u201310.","journal-title":"BMC Clin Pathol"},{"key":"4163_CR50","doi-asserted-by":"publisher","DOI":"10.2147\/HIV.S310905","author":"M Kiros","year":"2021","unstructured":"Kiros M, Mesfin Belay D, Getu S, Hailemichael W, Esmael A, Andualem H, et al. Prevalence and determinants of pre-cancerous cervical lesion and human papillomavirus among HIV-infected and HIV-uninfected women in North-West Ethiopia: a comparative retrospective cross-sectional study. HIV\/AIDS Res Palliat Care. 2021. https:\/\/doi.org\/10.2147\/HIV.S310905.","journal-title":"HIV\/AIDS Res Palliat Care"},{"issue":"3","key":"4163_CR51","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/LGT.0000000000000206","volume":"20","author":"CJ Chibwesha","year":"2016","unstructured":"Chibwesha CJ, Frett B, Katundu K, Bateman AC, Shibemba A, Kapambwe S, Mwanahamuntu MH, Banda S, Hamusimbi C, Polepole P. Clinical performance validation of four point-of-care cervical cancer screening tests in HIV-infected women in Zambia. J Lower Genit Tract Dis. 2016;20(3):218.","journal-title":"J Lower Genit Tract Dis"},{"key":"4163_CR52","volume-title":"Prevalence and predictors of cervical cytological (Pap Smear) abnormalities among HIV-infected women at the HIV","author":"OA Silas","year":"2020","unstructured":"Silas OA, Akpa PO, Afolaranmi TO, Ohayi SR, Musa J, Wehbe FH, Sagay AS, Achenbach CJ, Mandong BM, Hou L. Prevalence and predictors of cervical cytological (Pap Smear) abnormalities among HIV-infected women at the HIV. Nigeria: Treatment Center of Jos University Teaching Hospital Jos; 2020."},{"issue":"2","key":"4163_CR53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ijgo.13312","volume":"151","author":"GO Daniel","year":"2020","unstructured":"Daniel GO, Musa J, Akindigh TM, Shinku F, Shuaibu SI, Kwaghe B, et al. Prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, north-central Nigeria. Int J Gynaecol Obstet. 2020;151(2):253\u20139.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"4163_CR54","doi-asserted-by":"publisher","first-page":"e0263920","DOI":"10.1371\/journal.pone.0263920","volume":"17","author":"AK Korn","year":"2022","unstructured":"Korn AK, Muzingwani L, O\u2019Bryan G, Ensminger A, Boylan AD, Kafidi E-L, et al. Cervical cancer screening and treatment, HIV infection, and age: program implementation in seven regions of Namibia. PLoS One. 2022;17(2):e0263920.","journal-title":"PLoS One"},{"issue":"1","key":"4163_CR55","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/0956462418792653","volume":"30","author":"S Videla","year":"2019","unstructured":"Videla S, Tarrats A, Ornelas A, Badia R, Castella E, Alcalde C, Chamorro A, Est\u00e9 JA, Clotet B, Sirera G. Incidence of cervical high-grade squamous intraepithelial lesions in HIV-1-infected women with no history of cervical pathology: up to 17 years of follow-up. Int J STD AIDS. 2019;30(1):56\u201363.","journal-title":"Int J STD AIDS"},{"issue":"2","key":"4163_CR56","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1016\/S2214-109X(19)30527-3","volume":"8","author":"L Kuhn","year":"2020","unstructured":"Kuhn L, Saidu R, Boa R, Tergas A, Moodley J, Persing D, et al. Denny clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study. Lancet Glob Health. 2020;8(2):e296-304.","journal-title":"Lancet Glob Health"},{"key":"4163_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-015-1558-5","volume":"15","author":"AC Bateman","year":"2015","unstructured":"Bateman AC, Katundu K, Mwanahamuntu MH, Kapambwe S, Sahasrabuddhe VV, Hicks ML, et al. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. BMC Cancer. 2015;15:1\u20138.","journal-title":"BMC Cancer"},{"issue":"5","key":"4163_CR58","doi-asserted-by":"publisher","first-page":"e0003183","DOI":"10.1371\/journal.pgph.0003183","volume":"4","author":"RN Kassa","year":"2024","unstructured":"Kassa RN, Shifti DM, Alemu K, Omigbodun AO. Integration of cervical cancer screening into healthcare facilities in low-and middle-income countries: a scoping review. PLoS Glob Public Health. 2024;4(5):e0003183.","journal-title":"PLoS Glob Public Health"},{"issue":"7","key":"4163_CR59","doi-asserted-by":"publisher","first-page":"e0181156","DOI":"10.1371\/journal.pone.0181156","volume":"12","author":"L Sigfrid","year":"2017","unstructured":"Sigfrid L, Murphy G, Haldane V, Chuah FLH, Ong SE, Cervero-Liceras F, et al. Integrating cervical cancer with HIV healthcare services: a systematic review. PLoS One. 2017;12(7):e0181156.","journal-title":"PLoS One"},{"key":"4163_CR60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gore.2016.12.011","volume":"20","author":"O Afzal","year":"2017","unstructured":"Afzal O, Lieber M, Dottino P, Beddoe AM. Cervical cancer screening in rural South Africa among HIV-infected migrant farm workers and sex workers. Gynecol Oncol Rep. 2017;20:18\u201321.","journal-title":"Gynecol Oncol Rep"},{"issue":"1","key":"4163_CR61","first-page":"2","volume":"5","author":"R Mbu","year":"2019","unstructured":"Mbu R. Co-morbidity of HIV and cervical cancer: a one year multicentric pilot study in Cameroon. J HIV. 2019;5(1):2.","journal-title":"J HIV"},{"key":"4163_CR62","doi-asserted-by":"crossref","unstructured":"Haile EL, Cindy S, Ina B, Belay G, Sharon R, Lisbeth LR, Paul BJ. HPV testing on vaginal\/cervical nurse- assisted self-samples versus clinician-taken specimens and the HPV prevalence, in Adama town. Ethiopia Med. 2019;98(35).","DOI":"10.1097\/MD.0000000000016970"},{"issue":"1","key":"4163_CR63","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1200\/JGO.2015.002964","volume":"3","author":"RS Chambuso","year":"2017","unstructured":"Chambuso RS, Shadrack S, Lidenge SJ, Mwakibete N, Medeiros RM. Influence of HIV\/AIDS on cervical cancer: a retrospective study from Tanzania. J Glob Oncol. 2017;3(1):72\u20138.","journal-title":"J Glob Oncol"},{"key":"4163_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.910915","author":"W Zelalem","year":"2022","unstructured":"Zelalem W, Weldegebreal F, Ayele BH, Deressa A, Debella A, Eyeberu A, et al. Precancerous cervical lesion among adult women with human immune deficiency virus on anti retroviral therapy at Saint Peter specialized Hospital, Ethiopia: a hospital-based cross-sectional study. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.910915.","journal-title":"Front Oncol"},{"key":"4163_CR65","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5473681","author":"J Izudi","year":"2016","unstructured":"Izudi J, Adrawa N, Amongin D. Precancerous cervix in human immunodeficiency virus infected women thirty years old and above in Northern Uganda. J Oncol. 2016. https:\/\/doi.org\/10.1155\/2016\/5473681.","journal-title":"J Oncol"},{"issue":"6","key":"4163_CR66","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/jmv.24746","volume":"89","author":"G Ciccarese","year":"2017","unstructured":"Ciccarese G, Herzum A, Rebora A, Drago F. Prevalence of genital, oral, and anal HPV infection among STI patients in Italy. J Med Virol. 2017;89(6):1121\u20134.","journal-title":"J Med Virol"},{"key":"4163_CR67","first-page":"17","volume":"1","author":"Z Gessesse","year":"2015","unstructured":"Gessesse Z, Tadesse Z, Alemayehu M, Hiruye A, Getachew Y, Derbew M, et al. Determinant factors of visual inspection with acetic acid (VIA) positive lesions among HIV positive women in Mekelle Hospital, Northern ethiopia: a case control study. EMJ. 2015;1:17\u201324.","journal-title":"EMJ"},{"key":"4163_CR68","doi-asserted-by":"publisher","unstructured":"Kassa, R.T. Risk factors associated with precancerous cervical lesion among women screened at Marie Stops Ethiopia, Adama town, Ethiopia 2017: a case control study. BMC Res Notes. 2018;11(145). https:\/\/doi.org\/10.1186\/s13104-018-3244-6.","DOI":"10.1186\/s13104-018-3244-6"},{"key":"4163_CR69","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejogrb.2020.02.014","volume":"247","author":"S Asthana","year":"2020","unstructured":"Asthana S, Busa V, Labani S. Oral contraceptives use and risk of cervical cancer-a systematic review & meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;247:163\u201375.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"4163_CR70","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/ijc.28401","volume":"134","author":"MJ Huchko","year":"2014","unstructured":"Huchko MJ, Leslie H, Sneden J, Maloba M, Abdulrahim N, Bukusi EA, et al. Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya. Int J Cancer. 2014;134(3):740\u20135.","journal-title":"Int J Cancer"},{"issue":"1","key":"4163_CR71","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s12905-023-02580-0","volume":"23","author":"TM Dessie","year":"2023","unstructured":"Dessie TM, Kassaw AT, Alen GD. Determinants of precancerous cervical lesion among HIV infected women on ART in Woldia comprehensive specialized hospital Northeast Ethiopia. BMC Womens Health. 2023;23(1):458.","journal-title":"BMC Womens Health"},{"issue":"6","key":"4163_CR72","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","volume":"32","author":"G Liu","year":"2018","unstructured":"Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. AIDS. 2018;32(6):795\u2013808.","journal-title":"AIDS"},{"issue":"1","key":"4163_CR73","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S2352-3018(17)30149-2","volume":"5","author":"H Kelly","year":"2018","unstructured":"Kelly H, Weiss HA, Benavente Y, de Sanjose S, Mayaud P, Qiao Y-l, et al. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 2018;5(1):e45-58.","journal-title":"Lancet HIV"},{"issue":"8","key":"4163_CR74","doi-asserted-by":"publisher","first-page":"e015123","DOI":"10.1136\/bmjopen-2016-015123","volume":"7","author":"S Menon","year":"2017","unstructured":"Menon S, Rossi R, Zdraveska N, Kariisa M, Acharya SD, Broeck DV, Callens S. Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research. BMJ Open. 2017;7(8):e015123.","journal-title":"BMJ Open"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04163-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-04163-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04163-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:02:44Z","timestamp":1767063764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-025-04163-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4163"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-04163-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4668028\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval letter was obtained from the Institutional Review Board (IRB) of Bahir Dar University, College of Medicine and Health Sciences, with protocol number 593\/2022. All methods in the manuscript were conducted in accordance with relevant ethical guidelines and regulations established by the Declaration of Helsinki. After receiving ethical clearance, permission was issued by the Awi Zone Health Department, and an official letter of cooperation was obtained from the selected health facilities. After the purpose and importance of the study were explained, informed consent was obtained from each participant. Anonymity was maintained to ensure confidentiality by eliminating the names and other personal identifiers of participants throughout the study process and in the final report.The ethical approval letter was obtained from the Institutional Review Board (IRB) of Bahir Dar University, College of Medicine and Health Sciences, with protocol number 593\/2022. All methods in the manuscript were conducted in accordance with relevant ethical guidelines and regulations established by the Declaration of Helsinki. After receiving ethical clearance, permission was issued by the Awi Zone Health Department, and an official letter of cooperation was obtained from the selected health facilities. After the purpose and importance of the study were explained, informed consent was obtained from each participant. Anonymity was maintained to ensure confidentiality by eliminating the names and other personal identifiers of participants throughout the study process and in the final report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"622"}}